433 related articles for article (PubMed ID: 27490565)
1. Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications.
Nelson EA; Barnes AB; Wiehle RD; Fontenot GK; Hoenen T; White JM
Viruses; 2016 Aug; 8(8):. PubMed ID: 27490565
[TBL] [Abstract][Full Text] [Related]
2. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.
Johansen LM; Brannan JM; Delos SE; Shoemaker CJ; Stossel A; Lear C; Hoffstrom BG; Dewald LE; Schornberg KL; Scully C; Lehár J; Hensley LE; White JM; Olinger GG
Sci Transl Med; 2013 Jun; 5(190):190ra79. PubMed ID: 23785035
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
[TBL] [Abstract][Full Text] [Related]
4. The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection.
Nelson EA; Dyall J; Hoenen T; Barnes AB; Zhou H; Liang JY; Michelotti J; Dewey WH; DeWald LE; Bennett RS; Morris PJ; Guha R; Klumpp-Thomas C; McKnight C; Chen YC; Xu X; Wang A; Hughes E; Martin S; Thomas C; Jahrling PB; Hensley LE; Olinger GG; White JM
PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005540. PubMed ID: 28403145
[TBL] [Abstract][Full Text] [Related]
5. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
[TBL] [Abstract][Full Text] [Related]
6. Novel Small Molecule Entry Inhibitors of Ebola Virus.
Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
[TBL] [Abstract][Full Text] [Related]
7. Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection.
Shoemaker CJ; Schornberg KL; Delos SE; Scully C; Pajouhesh H; Olinger GG; Johansen LM; White JM
PLoS One; 2013; 8(2):e56265. PubMed ID: 23441171
[TBL] [Abstract][Full Text] [Related]
8. High-throughput drug screening using the Ebola virus transcription- and replication-competent virus-like particle system.
Lee N; Shum D; König A; Kim H; Heo J; Min S; Lee J; Ko Y; Choi I; Lee H; Radu C; Hoenen T; Min JY; Windisch MP
Antiviral Res; 2018 Oct; 158():226-237. PubMed ID: 30149038
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.
Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X
Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.
Covés-Datson EM; Dyall J; DeWald LE; King SR; Dube D; Legendre M; Nelson E; Drews KC; Gross R; Gerhardt DM; Torzewski L; Postnikova E; Liang JY; Ban B; Shetty J; Hensley LE; Jahrling PB; Olinger GG; White JM; Markovitz DM
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007595. PubMed ID: 31356611
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial screening of a panel of FDA-approved drugs identifies several candidates with anti-Ebola activities.
Du X; Zuo X; Meng F; Wu F; Zhao X; Li C; Cheng G; Qin FX
Biochem Biophys Res Commun; 2020 Feb; 522(4):862-868. PubMed ID: 31806372
[TBL] [Abstract][Full Text] [Related]
12. Specific neutralizing response in plasma from convalescent patients of Ebola Virus Disease against the West Africa Makona variant of Ebola virus.
Luczkowiak J; Arribas JR; Gómez S; Jiménez-Yuste V; de la Calle F; Viejo A; Delgado R
Virus Res; 2016 Feb; 213():224-229. PubMed ID: 26739425
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo.
Pessi A; Bixler SL; Soloveva V; Radoshitzky S; Retterer C; Kenny T; Zamani R; Gomba G; Gharabeih D; Wells J; Wetzel KS; Warren TK; Donnelly G; Van Tongeren SA; Steffens J; Duplantier AJ; Kane CD; Vicat P; Couturier V; Kester KE; Shiver J; Carter K; Bavari S
Antiviral Res; 2019 Nov; 171():104592. PubMed ID: 31473342
[TBL] [Abstract][Full Text] [Related]
14. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.
Shrivastava-Ranjan P; Flint M; Bergeron É; McElroy AK; Chatterjee P; Albariño CG; Nichol ST; Spiropoulou CF
mBio; 2018 May; 9(3):. PubMed ID: 29717011
[TBL] [Abstract][Full Text] [Related]
15. Second generation of diazachrysenes: Protection of Ebola virus infected mice and mechanism of action.
Selaković Ž; Tran JP; Kota KP; Lazić M; Retterer C; Besch R; Panchal RG; Soloveva V; Sean VA; Jay WB; Pavić A; Verbić T; Vasiljević B; Kuehl K; Duplantier AJ; Bavari S; Mudhasani R; Šolaja BA
Eur J Med Chem; 2019 Jan; 162():32-50. PubMed ID: 30408747
[TBL] [Abstract][Full Text] [Related]
16. Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry.
Henß L; Beck S; Weidner T; Biedenkopf N; Sliva K; Weber C; Becker S; Schnierle BS
Virol J; 2016 Aug; 13(1):149. PubMed ID: 27581733
[TBL] [Abstract][Full Text] [Related]
17. Synergistic drug combination effectively blocks Ebola virus infection.
Sun W; He S; Martínez-Romero C; Kouznetsova J; Tawa G; Xu M; Shinn P; Fisher E; Long Y; Motabar O; Yang S; Sanderson PE; Williamson PR; García-Sastre A; Qiu X; Zheng W
Antiviral Res; 2017 Jan; 137():165-172. PubMed ID: 27890675
[TBL] [Abstract][Full Text] [Related]
18. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor.
Cheng H; Schafer A; Soloveva V; Gharaibeh D; Kenny T; Retterer C; Zamani R; Bavari S; Peet NP; Rong L
Antiviral Res; 2017 Sep; 145():24-32. PubMed ID: 28645623
[TBL] [Abstract][Full Text] [Related]
19. Antiviral effect of ranpirnase against Ebola virus.
Hodge T; Draper K; Brasel T; Freiberg A; Squiquera L; Sidransky D; Sulley J; Taxman DJ
Antiviral Res; 2016 Aug; 132():210-8. PubMed ID: 27350309
[TBL] [Abstract][Full Text] [Related]
20. Identification of Diaryl-Quinoline Compounds as Entry Inhibitors of Ebola Virus.
Cui Q; Cheng H; Xiong R; Zhang G; Du R; Anantpadma M; Davey RA; Rong L
Viruses; 2018 Nov; 10(12):. PubMed ID: 30513600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
